Digital Smarter learning and better outcomes: How AI can provide an ... AI is revolutionising medical education, optimising learner outcomes and, ultimately, improving real-world patient care.
Views & Analysis Listening to the Patient Voice: Collaborate to meet unmet in... Pharma has a real willingness to listen to the patient voice – but how best can we turn that desire into action?
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.